- Home
- VIP vs DYAI Comparison
VIP vs DYAI Comparison
Compare VIP & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VIP | DYAI |
|---|---|---|
| Founded | N/A | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.8M | 32.5M |
| IPO Year | 2021 | 2003 |
Fundamental Metrics
Financial Performance| Metric | VIP | DYAI |
|---|---|---|
| Price | $1.84 | $0.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | ★ 309.3K | 205.3K |
| Earning Date | N/A | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 118.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $70,388,000.00 | $3,090,345.00 |
| Revenue This Year | N/A | $122.79 |
| Revenue Next Year | N/A | $100.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.55 | $0.65 |
| 52 Week High | $2.74 | $1.60 |
Technical Indicators
Market Signals| Indicator | VIP | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 29.83 | 37.27 |
| Support Level | $1.55 | $0.76 |
| Resistance Level | $2.25 | $0.95 |
| Average True Range (ATR) | 0.18 | 0.11 |
| MACD | -0.03 | -0.04 |
| Stochastic Oscillator | 37.14 | 7.71 |
Price Performance
Historical ComparisonAbout VIP Vulcan Infrastructure and Power Inc. Class A Common Stock
Vulcan Infrastructure and Power Inc is a power and infrastructure platform focused on acquiring, developing and operating energized sites that support artificial intelligence and high-performance computing data centers, as well as local electricity grids.
About DYAI Dyadic International Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.